Skye Bioscience, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Skye Bioscience, Inc. (SKYE) is 13.78M

According to Skye Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.78M. This represents a change of -82.82% compared to the average of 80.19M of the last 4 quarters.

Skye Bioscience, Inc. (SKYE) Historical Enterprise Value (quarterly & annually)

How has SKYE Enterprise Value performed in the past?

The mean historical Enterprise Value of Skye Bioscience, Inc. over the last ten years is 19.23M. The current 13.78M Enterprise Value has changed 7.06% with respect to the historical average. Over the past ten years (40 quarters), SKYE's Enterprise Value was at its highest in in the March 2024 quarter at 318.53M. The Enterprise Value was at its lowest in in the March 2018 quarter at 2.33M.

Skye Bioscience, Inc. (SKYE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Skye Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Skye Bioscience, Inc. (SKYE) Average Enterprise Value

How has SKYE Enterprise Value performed in the past?

The current Enterprise Value of Skye Bioscience, Inc. (SKYE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Skye Bioscience, Inc. (SKYE) Enterprise Value vs. Peers

How is SKYE’s Enterprise Value compared to its peers?

Skye Bioscience, Inc.’s Enterprise Value is greater than Aligos Therapeutics, Inc. (498.95K), greater than Xilio Therapeutics, Inc. (-83861235.00), less than Mersana Therapeutics, Inc. (91.27M), less than INmune Bio, Inc. (25.08M), less than X4 Pharmaceuticals, Inc. (237.62M), greater than Kezar Life Sciences, Inc. (-11018667.00), greater than Barinthus Biotherapeutics plc (-32745991.00), greater than LAVA Therapeutics N.V. (-3892787.00), less than PDS Biotechnology Corporation (31.65M), less than CEL-SCI Corporation (14.46M),

Build a custom stock screener for Skye Bioscience, Inc. (SKYE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Skye Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Skye Bioscience, Inc. (SKYE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Skye Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.